Table 1

Patient overview and tumor status

Patient ID

Gender

Type

Primary tumor grade

Metastasis resectiona

Treatmentb


Patient 1

Female

Adenocarcinoma

Moderately differentiated

3 months

No treatment

Patient 2

Male

Adenocarcinoma

Moderately differentiated

20 months

No treatment

Patient 3

Male

Adenocarcinoma

Poorly differentiated

10 months

XELOXc and Bevacizumab

Patient 4

Female

Adenocarcinoma

Well differentiated

9 months

5FU, leucovorin, oxaliplatin, bevacizumab


aTime between primary resection and metastasis resection. bTreatment after primary tumor resection. cCapecitabine and oxaliplatin. 5FU, fluorouracil.

Kloosterman et al. Genome Biology 2011 12:R103   doi:10.1186/gb-2011-12-10-r103

Open Data